|
시장보고서
상품코드
2051033
공간 오믹스 시장 : 기술 유형별, 제품 유형별, 워크플로우별, 샘플별, 최종사용자별, 지역별Spatial Omics Market, By Technology Type, By Product Type, By Workflow, By Sample Type, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
공간 오믹스 시장은 2026년에 3억 4,710만 달러로 추정되며, 2033년에 6억 6,780만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 9.8%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 3억 4,710만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 9.80% | 2033년 시장 규모 예측: | 6억 6,780만 달러 |
지난 몇 년 동안 공간 오믹스 기술이 등장하여 유전체학, 전사체학, 단백질체학, 대사체학 등 다세포 생물 시스템을 이해하는 방식을 바꾸어 놓았습니다.
기존의 단백질체학 및 전사체학은 개별 세포 집단의 식별 및 기타 병리학적 과제를 통해 질병의 증식에 대한 상세한 지식을 제공해 왔습니다. 또한, 공간 오믹스 기법은 질량 분석법과 마찬가지로 세포조직의 발현 프로파일을 고해상도로 매핑할 수 있습니다. 시료 내 다양한 세포의 공간적 정보를 세포의 형태 및 주변 세포외기질(ECM)과 함께 보유할 수 있는 능력은 스페이서오믹스에 미개발된 신호전달 양식을 탐색할 수 있는 기회를 제공할 수 있습니다.
스타트업과 중소기업의 공간 유전체학에 대한 수용이 급증하고 있으며, 바이오마커 식별에 대한 대규모 활용이 시장을 주도할 것으로 보입니다. 또한, 신약개발과 신약개발에서 공간 유전체학의 적용 확대는 공간 오믹스 산업에 수익성 높은 길을 열어줄 것입니다.
시장 역학
암 환자 수 증가, R&D 활동 증가, 주요 기업들의 합병, 인수, 제휴, 공동 연구와 같은 비유기적 성장 전략의 채택 확대는 예측 기간 동안 세계 공간 오믹스 시장의 성장을 견인하는 주요 요인으로 작용할 것으로 예상됩니다.
미국암협회(American Cancer Society)에 따르면, 2022년 미국에서는 약 9만 9,780건의 신규 흑색종이 진단될 것으로 예상되며(남성 약 5만 7,180건, 여성 약 4만 2,600건), 약 7,650명이 흑색종으로 사망할 것으로 예상됩니다(남성 약 5,080명, 여성 약 2,570명).
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 스페이스 오믹스 시장의 주요 진입 업체를 프로파일링합니다. 회사개요, 재무실적, 제품 포트폴리오,시장현황,유통전략, 주요 개발, 전략,향후 계획
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계 스페이스 오믹스 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 공간 오믹스 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 할 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 공간 오믹스 시장 : 기술 유형별, 2021-2033년
제5장 세계의 공간 오믹스 시장 : 제품 유형별, 2021-2033년
제6장 세계의 공간 오믹스 시장 : 워크플로우별, 2021-2033년
제7장 세계의 공간 오믹스 시장 : 샘플 유형별, 2021-2033년
제8장 세계의 공간 오믹스 시장 : 최종사용자별, 2021-2033년
제9장 세계의 공간 오믹스 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 섹션
KSM 26.06.16Spatial Omics Market is estimated to be valued at USD 347.1 Mn in 2026 and is expected to reach USD 667.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 347.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.80% | 2033 Value Projection: | USD 667.8 Mn |
Spatial omics technologies have emerged during the last few years and have changed the way we understand multicellular biological systems, which includes genomics, transcriptomics, proteomics, and metabolomics.
Conventional proteomics and transcriptomics have provided granular insights into disease proliferation via identification of discrete cell population along with other pathological issues. Moreover, spatial omics methods provide high resolution mapping of expression profiles of cell tissues similar to that provided by mass spectrometry. Ability to retain spatial content of various cells in samples along with their cellular geometry and surrounding extracellular matrix (ECM) is likely to offer spatial omics with an opportunity to explore unexplored signal modalities.
Surge in acceptance of spatial genomics by start-ups and small firms along with its massive use in biomarker identification will drive the market, in addition to this, rise in application of spatial genomics in drug development and medicine discovery will create lucrative avenues for spatial omics industry.
Market Dynamics
The increasing population of cancers, rising research and development activities, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global spatial omics market over the forecast period.
According to American Cancer Society, in the U.S in 2022, about 99,780 new melanomas will be diagnosed (about 57,180 in men and 42,600 in women) and about 7,650 people are expected to die of melanoma (about 5,080 men and 2,570 women).
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global spatial omics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode Diagnostics, Fluidigm Corporation, IonPath Inc., Millennium Science Pty Ltd, NanoString Technologies, PerkinElmer, Rebus Biosystems, Ultivue Inc., Vizgen Corp, Dovetail Genomics, S2 Genomics, Inc., Seven Bridges Genomics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global spatial omics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spatial omics market
Market Segmentation
- Global Spatial Omics Market, By Technology Type (Revenue, USD Mn, 2021 - 2033)
- Spatial Proteomics
- Spatial Transcriptomics
- Spatial Genomics
- Global Spatial Omics Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
- Instruments
- Consumables
- Software
- Global Spatial Omics Market, By Workflow (Revenue, USD Mn, 2021 - 2033)
- Sample Preparation
- Instrumental Analysis
- Data Analysis
- Global Spatial Omics Market, By Sample Type (Revenue, USD Mn, 2021 - 2033)
- FFPE
- Fresh Frozen
- Global Spatial Omics Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Academics & Translational Research Institutes
- Pharmaceutical & Biotechnology Companies
- Global Spatial Omics Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players Insights
- 10x Genomics
- Akoya Bioscience Inc.
- Biognosys AG
- BioSpyder Technologies
- Bio-Techne
- Bruker
- Brooks Automation Inc.
- Danaher Corporation
- Diagenode Diagnostics
- Fluidigm Corporation
- IonPath Inc.
- Millennium Science Pty Ltd
- NanoString Technologies
- PerkinElmer
- Rebus Biosystems
- Ultivue Inc.
- Vizgen Corp
- Dovetail Genomics
- S2 Genomics, Inc.
- Seven Bridges Genomics.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology Type
- Market Snippet, By Product Type
- Market Snippet, By Workflow
- Market Snippet, By Sample Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Mergers & Acquisitions
4. Global Spatial Omics Market, By Technology Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Spatial Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Spatial Transcriptomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Spatial Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Global Spatial Omics Market, By Product Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global Spatial Omics Market, By Workflow, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Sample Preparation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Instrumental Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Data Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
7. Global Spatial Omics Market, By Sample Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- FFPE
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Fresh Frozen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
8. Global Spatial Omics Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Academics & Translational Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
9. Global Spatial Omics Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- North America
- Market Size and Forecast, By Technology Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Technology Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Technology Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Technology Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Technology Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Technology Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Workflow, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
- South Africa
- Central Africa
- North Africa
10. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- 10x Genomics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Akoya Bioscience Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Biognosys AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BioSpyder Technologies
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bio-Techne
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bruker
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Brooks Automation Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Danaher Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Diagenode Diagnostics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Fluidigm Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- IonPath Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Millennium Science Pty Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- NanoString Technologies
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- PerkinElmer
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Rebus Biosystems
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Ultivue Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vizgen Corp
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dovetail Genomics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- S2 Genomics, Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Seven Bridges Genomics
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- 10x Genomics
11. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. Section
- References
- Research Methodology
- About Us and Sales Contact
